EMPALIX 25
EMPALIX 25 contains Empagliflozin 25 mg, a higher-strength SGLT2 inhibitor used for better control of type 2 diabetes. It works by increasing glucose excretion through urine, helping reduce blood sugar levels effectively. Along with glycemic control, it supports weight management and offers proven cardiovascular and kidney protection, making it a suitable choice for patients needing stronger and long-term diabetes care.
About brand
Parturient ut id tellus vulputatre ac ultrlices a part ouriesnt sapien dignissim partu rient a a inter drum vehicula. Ornare metus laoreet tincidunt eros rolem tristique pretium malada.
Cras rhoncus vivamus luctus platea arcu laoreet selm. Curae est condenectus sed hac a parturient vestibulum.
Related products
SITAMATA 50-500
SITAMATA 50-500 contains Sitagliptin 50 mg + Metformin Hydrochloride 500 mg, a balanced combination used...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
EVOGLIX
EVOGLIX M 500 Tablet is a combination medicine used to manage type 2 diabetes effectively....
DUET ACT 4 FORTE
DUET ACT 4 FORTE Tablet is a combination medicine used for managing type 2 diabetes...
DUET ACT 2
DUET ACT 2 combines Glimepiride 2 mg with Metformin 500 mg (SR) for better blood...
DAPAGLIDE M 1000
DAPAGLIDE M 1000 Tablet is a combination medicine used for managing type 2 diabetes effectively....
